Dr. Youssef Khaled Barbour, MD

Dr. Barbour practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Barbour's NPI, 1588846042, was assigned on November 27, 2007. Dr. Barbour holds Alaska license 4526.

Dr. Barbour's primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Barbour's primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. Dr. Barbour is also affiliated with Mt. Edgecumbe Medical Center. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Barbour to 1 more hospital and 4 medical groups, each named with a free account. Dr. Barbour's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barbour practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Barbour's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Barbour is licensed in Alaska.

CMS data shows 169 Medicare services from Dr. Barbour across 3 procedure codes in 2024, for 128 Medicare patients. Medicare paid $7,885 for them.

CMS counts 128 Medicare patients who saw Dr. Barbour in 2024. The largest group is 65 to 74, with 74 patients. 68% of them have high blood pressure, and 45% have high cholesterol. 54% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barbour's median patient age at 69, with 58% women.

In 2024, Dr. Barbour wrote 46 Medicare Part D claims for 17 patients. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $109 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Barbour for performance year 2024, reported as part of a group. Dr. Barbour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barbour as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 18 general payments to Dr. Barbour from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $599.